ES2116574T3 - 4-guanidinobutiramida para mejorar la circulacion de la sangre. - Google Patents

4-guanidinobutiramida para mejorar la circulacion de la sangre.

Info

Publication number
ES2116574T3
ES2116574T3 ES94902887T ES94902887T ES2116574T3 ES 2116574 T3 ES2116574 T3 ES 2116574T3 ES 94902887 T ES94902887 T ES 94902887T ES 94902887 T ES94902887 T ES 94902887T ES 2116574 T3 ES2116574 T3 ES 2116574T3
Authority
ES
Spain
Prior art keywords
pct
improve
circulation
guanidinobutiramida
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94902887T
Other languages
English (en)
Inventor
William John Hughe Butterfield
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cemorc Ltd
Original Assignee
Cemorc Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929226313A external-priority patent/GB9226313D0/en
Priority claimed from GB939303688A external-priority patent/GB9303688D0/en
Application filed by Cemorc Ltd filed Critical Cemorc Ltd
Application granted granted Critical
Publication of ES2116574T3 publication Critical patent/ES2116574T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)

Abstract

EL 4-GUANIDINOBUTIRAMIDA, O UNA SAL FISIOLOGICAMENTE ACEPTABLE DE LA MISMO, TIENE EL DESEABLE EFECTO DE MEJORAR LA CIRCULACION DE LA SANGRE.
ES94902887T 1992-12-17 1993-12-17 4-guanidinobutiramida para mejorar la circulacion de la sangre. Expired - Lifetime ES2116574T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929226313A GB9226313D0 (en) 1992-12-17 1992-12-17 Therapeutic treatment
GB939303688A GB9303688D0 (en) 1993-02-24 1993-02-24 Therapeutic treatment

Publications (1)

Publication Number Publication Date
ES2116574T3 true ES2116574T3 (es) 1998-07-16

Family

ID=26302171

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94902887T Expired - Lifetime ES2116574T3 (es) 1992-12-17 1993-12-17 4-guanidinobutiramida para mejorar la circulacion de la sangre.

Country Status (11)

Country Link
US (1) US5684047A (es)
EP (1) EP0674508B1 (es)
JP (1) JPH08504436A (es)
AT (1) ATE167055T1 (es)
AU (1) AU674376B2 (es)
CA (1) CA2151734A1 (es)
DE (1) DE69319140T2 (es)
DK (1) DK0674508T3 (es)
ES (1) ES2116574T3 (es)
GR (1) GR3027682T3 (es)
WO (1) WO1994013276A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1195200A (en) * 1967-02-07 1970-06-17 Horlicks Pharmaceuticals Ltd Pharmaceutical Compositions.
US3639628A (en) * 1969-07-22 1972-02-01 Beecham Group Ltd Method of lowering abnormally high level of blood urea
JPH03240772A (ja) * 1990-02-19 1991-10-28 Eisai Co Ltd 循環不全治療剤
US5246971A (en) * 1991-12-16 1993-09-21 Washington University Method of inhibiting nitric oxide formation

Also Published As

Publication number Publication date
WO1994013276A1 (en) 1994-06-23
AU674376B2 (en) 1996-12-19
ATE167055T1 (de) 1998-06-15
DE69319140D1 (de) 1998-07-16
AU5706194A (en) 1994-07-04
JPH08504436A (ja) 1996-05-14
US5684047A (en) 1997-11-04
EP0674508B1 (en) 1998-06-10
EP0674508A1 (en) 1995-10-04
DK0674508T3 (da) 1999-03-22
GR3027682T3 (en) 1998-11-30
CA2151734A1 (en) 1994-06-23
DE69319140T2 (de) 1998-10-01

Similar Documents

Publication Publication Date Title
FI946004A0 (fi) Lääketieteellisessä toimenpiteessä käytettävä trombiiniverifraktio
ATE114113T1 (de) Verwendung von droloxifen bei der behandlung von knochenerkrankungen.
ATE81978T1 (de) Verwendung von 3'-azido-3'-deoxythymidin zur behandlung oder vorbeugung von menschlichen retrovirus-infektionen.
DE68907553D1 (de) Make-up-mittel zur menschlichen anwendung.
NO931809D0 (no) Hemofilter
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
DE69202739T2 (de) Gemischtes Alkylmethylsiloxane zur Hautpflege.
DE69326776D1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
DE69117541T2 (de) Implantat mit durchgangsöffnung
DE69616340T2 (de) Fungizide mischungen
ATE201680T1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure- additions-salze
MX9401406A (es) Agentes receptores de adenosina selectivos para intensificar el conocimiento.
ATE167690T1 (de) Polyetheramidoamine hydrogele als heparinersatz
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
GB9227123D0 (en) Method
DK0482108T3 (da) Substituerede 2-imidazoliner samt fremstilling og anvendelse deraf
ES2116574T3 (es) 4-guanidinobutiramida para mejorar la circulacion de la sangre.
ATE200624T1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
NO882313D0 (no) Desinfeksjonsmiddel og anvendelse av dette for aa desinfisere hud og overflater paa gjenstander.
SE9403861D0 (sv) Novel medicinal use
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.
DE58908686D1 (de) Lederbehandlungsmittel.
ES2181160T3 (es) Derivados de 1,4-dihidropiridina y su utilizacion en terapia.
DE3765250D1 (de) Verwendung von 24,25-dihydroxycholecalciferol zur behandlung von harnsteinen.
DE68905479T2 (de) Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 674508

Country of ref document: ES